Enterprise Assurance control plane
Backup proves it was copied. We prove whether it should be used.
GenomeX Assurance Platform is not five products. It is one control plane, five shared engines, and five domain gates. It sits above backup, EDR, CI/CD, and AI stacks — converting their signals into a governed ALLOW / DENY / CONFIRM decision, with a receipt you can verify offline.
Can this digital asset be trusted before the enterprise uses it — and can that decision be proven?
How the product is organized
DAB is the librarian. The engines are the inspectors. The domains are the gates.
Domains differ in policy objects, buyer questions, and receipts — not in duplicated worker fleets.
Trust before use
Proof after decision
128D Behavioral Genome · 8 blocks × 16 slots
Before-use gate
ALLOWReceipt minted
DENYBlock the use
CONFIRMHuman review
Discover
Discover-Aligned Bridge
GX-DAB · catalog what exists and what may proceed
Materialize
Sequence Engine
GX-SEQ · open truth far enough for an explainable decision
Evaluate
Behavior Engine
GX-BE · 128D genome · drift · confidence
Prove
Assurance Ledger
GX-AL · local-first receipt · Merkle · ledger anchor
The assurance gap
Data has become infrastructure. Trust has not.
Recovery points, corpora, training sets, releases, and agent actions now participate in operations. Existing tools answer availability, detection, and vulnerability — not whether the asset should proceed at the moment of use.
Re-infection fear
A hardened repository can faithfully preserve ransomware. A clean recovery point can sit on a drifted backup platform.
Validation does not scale
Physical clean rooms work for one critical workload. They do not rank hundreds of recovery points after an incident.
No portable proof
DORA, HIPAA, cyber insurance, and internal audit need artifacts — not an administrator's opinion.
One processing spine
Every governed asset follows the same discipline.
The asset changes. The before-use moment changes. Fusion and proof stay consistent.
1
Asset
Identify
Recovery point, corpus, dataset, release, or agent action.
2
GX-DAB
Discover
Catalog what exists and which subset may proceed.
3
GX-SEQ
Open
Materialize truth far enough for an explainable decision.
4
GX-SIG
Sign
Known-bad signatures and IOCs on materialized content.
5
GX-BE
Evaluate
Behavior, drift, confidence on the 128D genome.
6
GX-AL
Prove
Local-first receipt, Merkle binding, ledger anchor.
7
Policy
Decide
ALLOW, DENY, or CONFIRM with evidence attached.
Five domain gates
Same assurance model. Different before-use moment.
Enter through the domain where risk is most concrete. The platform underneath is the same.
Recovery Assurance
Can this recovery chain be trusted before restore?
Restore Authority · PoS-B
Recovery Environment Genome + Recovery Asset Genome → ALLOW / CONFIRM / DENY
Knowledge Assurance
Can this knowledge be trusted before it is indexed?
Pre-index gate · KAR
Provenance, hidden instructions, ingestion drift before embed
ML Assurance
Can this dataset or ML asset be trusted before training?
Training gate · ML-BOM
Dataset hash, schema hash, training-gate decision
Agent Assurance
Can this agent be trusted before it acts?
Action gate · AAR
Tool calls, delegations, runtime behavior vs family baseline
Software Assurance
Can this release be trusted before deploy?
Release gate · SBOM / CBOM
Provenance, lineage, dependency posture — CVE is input, not the decision
Evidence that leaves with you
Decisions without receipts do not survive audit.
Every domain gate can mint a portable assurance receipt: platform genome, fusion lanes, policy version, and — for recovery — dual genomes in an offline-verifiable exit pack.
Fusion lanes
Behavioral, materialized content, anomaly, signature, and integrity — fused into one decision, not a decorative score.
Industry views
Same receipts, different lens: CISO posture, GRC audit pack, insurance cohort, MSSP tenant rollup.
Escalate only
Policy never silently downgrades risk. CONFIRM is a first-class state, not a failure mode.
Exit pack
Receipt + both genomes + fusion + policy — verifiable without the GenomeX API or your original host.
Evidence boundary
Overlay, not replacement. Honest about what we measure.
What GenomeX adds
- Trust decision before restore, index, train, deploy, or act
- 128D Behavioral Genome shared across all domains
- ALLOW / DENY / CONFIRM with confidence and attribution
- Portable receipts for audit, insurance, and board scrutiny
- Vendor-agnostic connectors — Veeam, Cohesity, GitHub, SharePoint, agent frameworks
What GenomeX is not
- Not a backup platform — consumes backup state as evidence
- Not EDR / XDR — governs cold content at backup scale
- Not an AppSec scanner — fuses SCA/SBOM into release trust
- Not a runtime LLM firewall — governs upstream corpora and agents
- Not immunity, guaranteed clean, or weeks-to-hours patch SLA
Who enters first
The first buyer varies. The platform does not.
CISO
Security leadership
Intervention rate, CONFIRM queue, domain posture after ransomware planning.
Backup / DR
Infrastructure
Restore Authority: environment genome + asset genome before any actuator runs.
AI platform
Knowledge & agents
Gate corpora before RAG, datasets before training, agents before tool execution.
Insurer / MSSP
Evidence consumers
Cohort posture and exportable receipts — not questionnaire attestation.
GenomeX family
Same behavioral engine. Different operational surface.
GenomeX Assurance Platform is the enterprise control plane. Sibling products apply the same 128-dimensional behavioral model to other markets — without duplicating the engine.
You are here
GenomeX Assurance Platform
Enterprise Assurance before restore, index, train, deploy, or act. Five domain gates, one receipt model.
On-chain behavioral substrate
BlockchainDNA
Identity, provenance, and behavioral governance for wallets, assets, and AI agents on live chains.
Institutional named watch
Cha-Ching Analytics
Desk workflow on BlockchainDNA evidence — Attention, Facts, Convergence, Transact now.
Engagement
Enterprise Assurance is implemented, not slideware.
Pilot, lab validation, and OEM paths are available. Pricing follows deployment scope and domain entry point.
Domain pilot
Lab / scoped
- Single domain gate — typically GX-GRA or GX-GSA
- Connector baseline + authorize + receipt export
- Shared engines under production policy objects
- 90-day validation with defined success criteria
Enterprise platform
Contact / annual
- Multi-domain control plane + industry views
- MSSP / insurance evidence projections
- Offline-verifiable exit packs and audit bundles
- Implementation and 12–36 month transition support
OEM & platform
Partner / license
- Embed domain gates in backup, AppSec, or AI platforms
- Receipt and genome wire under your product surface
- IP licensing via Knight Global Enterprises
- U.S. implementation via Knight InfoTek
Tomorrow, trust will be measured — not assumed.
As digital assets become infrastructure, trust must become measurable infrastructure as well. GenomeX Assurance Platform is how enterprises govern that transition.